FFA
EW icon

Frazier Financial Advisors’s Edwards Lifesciences EW Stock Holding History

Frazier Financial Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$102K Sell
1,278
-124
-9% -$10.2K 0.06% 115
2025
Q4 		$120K Buy
1,402
+124
+10% +$10.2K 0.07% 95
2025
Q3 		$99.4K Hold
1,278
– – 0.06% 102
2025
Q2 		$100K Sell
1,278
-24
-2% -$1.79K 0.07% 99
2025
Q1 		$94.4K Hold
1,302
– – 0.07% 90
2024
Q4 		$96.7K Buy
1,302
+30
+2% +$2.1K 0.08% 87
2024
Q3 		$83.9K Hold
1,272
– – 0.07% 101
2024
Q2 		$117K Sell
1,272
-43
-3% -$3.81K 0.09% 88
2024
Q1 		$126K Sell
1,315
-115
-8% -$9.66K 0.1% 85
2023
Q4 		$109K Buy
+1,430
New +$99.5K 0.09% 82

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Frazier Financial Advisors's EW Position: Q1 2026 in Review

Frazier Financial Advisors reduced its Edwards Lifesciences (EW) stake by 8.8% in Q1 2026, selling an estimated $10.2K and leaving 1,278 shares worth $102K. The position accounts for 0.06% of the portfolio, ranked #115.

Frazier Financial Advisors first reported a position in EW in Q4 2023 and has held it in 10 quarters since. The position peaked at $126K in Q1 2024. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Frazier Financial Advisors held 1,278 shares of Edwards Lifesciences worth $102K as of Q1 2026.
  • Frazier Financial Advisors sold 124 Edwards Lifesciences shares in Q1 2026, an estimated $10.2K.
  • Edwards Lifesciences made up 0.06% of Frazier Financial Advisors's portfolio in Q1 2026, its #115 holding.
  • Frazier Financial Advisors first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 10 quarters since.
  • Frazier Financial Advisors's Edwards Lifesciences position peaked at $126K in Q1 2024.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Frazier Financial Advisors's 13F filing for Q1 2026, filed 5 May 2026.